Interventions on the Superficial Venous System for Chronic Venous Insufficiency by Surgeons in the Modern Era

Abstract

Objective:

To evaluate patient characteristics, practice patterns, and outcomes for patients treated for chronic venous insufficiency (CVI).

Background:

Chronic venous insufficiency is a common problem treated using open or endovascular methods by physicians from a number of surgical and nonsurgical specialties.

Methods:

Patients treated for CVI in the American College of Surgeons National Surgical Quality Improvement Program data set (2005-2011) were identified. Analyses were based on open surgical treatment (open surgery of varicose vein [OSVV]) versus endovenous ablation (EVA), specialty of treating surgeon, and by the presence of venous ulceration (VU). Preoperative patient characteristics and intraoperative measures were examined, and multivariate logistic regression analyses were performed for the postoperative outcomes of superficial surgical site infection (sSSI) and deep venous thrombosis (DVT).

Results:

A total of 4366 patients were identified. Patients undergoing EVA were older (53.3 vs 51.8 years; P < .001), had higher body mass index (BMI; 29.9 vs 29.0; P < .001), and more commonly presented with VU (20.9% vs 13.3%; P < .001). Vascular surgeons were more likely than general surgeons to treat patients with VU (17.0% vs 13.4%; P = .017). Patients with VU had higher BMI (32.2 vs 28.8; P < .001), were older (57.9 vs 51.4 years; P < .001), and more likely to be diabetic (9.0% vs 4.7%; P < .001). Factors associated with sSSI were OSVV (adjusted odds ratio [AOR] 2.56; 95% confidence interval [CI] 1.19-5.50; P = .016), obesity (AOR 2.16; 95% CI 1.10-4.24; P = .025), and VU (AOR 2.56; 95% CI 1.19-5.50; P = .016). Patients undergoing OSVV had significantly lower odds of DVT when compared to EVA (AOR 0.52; 95% CI 0.28-0.97; P = .040).

Conclusions:

The OSVV, obesity, and VU increase the odds of sSSI after procedures treating CVI. Patients in these categories should be monitored closely for signs of infection in the perioperative period. Patients undergoing EVA have higher odds of postoperative DVT, suggesting that routine screening after EVA for DVT may be justified.

Keywords

chronic venous insufficiency varicose veins venous ablation radiofrequency ablation laser ablation saphenous vein stripping phlebectomy deep venous thrombosis surgical site infection

Get full access to this article

View all access options for this article.

References

Cronenwett

Johnston

. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders; 2010.

Meissner

Gloviczki

Bergan

. Primary chronic venous disorders. J Vasc Surg. 2007;46 (6):S54–S67. doi:10.1016/j.jvs.2007.08.038.

Criqui

Jamosmos

Fronek

. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. Am J Epidemiol. 2003;158 (5):448–456.

Van den Oever

Hepp

Debbaut

Simon

Socio-economic impact of chronic venous insufficiency. An underestimated public health problem. Int Angiol. 1998;17 (3):161–167.

Brown

Rossi

. Superficial venous disease. Surg Clin North Am. 2013;93 (4):963–982. doi:10.1016/j.suc.2013.04.007.

Evans

Fowkes

Ruckley

Lee

. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health. 1999;53 (3):149–153.

Eklof

Rutherford

Bergan

. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40 (6):1248–1252. doi:10.1016/j.jvs.2004.09.027.

Winterborn

Foy

Heather

Earnshaw

. Randomised trial of flush saphenofemoral ligation for primary great saphenous varicose veins. Eur J Vasc Endovasc Surg. 2008;36 (4):477–484. doi:10.1016/j.ejvs.2008.06.022.

Scheltinga

Wijburg

Keulers

de Kroon

. Conventional versus invaginated stripping of the great saphenous vein: a randomized, double-blind, controlled clinical trial. World J Surg. 2007;31 (11):2236–2242. doi:10.1007/s00268-007-9211-3.

10.

Chandler

Pichot

Sessa

Schuller-Petrović

Osse

Bergan

. Defining the role of extended saphenofemoral junction ligation: a prospective comparative study. J Vasc Surg. 2000;32 (5):941–953. doi:10.1067/mva.2000.110348.

11.

Dwerryhouse

Davies

Harradine

Earnshaw

. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: five-year results of a randomized trial. J Vasc Surg. 1999;29 (4):589–592. doi:10.1016/S0741-5214(99)70302-2.

12.

Nordon

Hinchliffe

Brar

. A prospective double-blind randomized controlled trial of radiofrequency versus laser treatment of the great saphenous vein in patients with varicose veins. Ann Surg. 2011;254 (6):876–881. doi:10.1097/SLA.0b013e318230af5a.

13.

van den Bos

Arends

Kockaert

Neumann

Nijsten

. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg. 2009;49 (1):230–239. doi:10.1016/j.jvs.2008.06.030.

14.

Luebke

Brunkwall

. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg (Torino). 2008;49 (2):213–233.

15.

Morrison

. Saphenous ablation: what are the choices, laser or RF energy. Semin Vasc Surg. 2005;18 (1):15–18.

16.

Rasmussen

Lawaetz

Bjoern

Blemings

Eklof

. Randomized clinical trial comparing endovenous laser ablation and stripping of the great saphenous vein with clinical and duplex outcome after 5 years. J Vasc Surg. 2013;58 (2):421–426. doi:10.1016/j.jvs.2012.12.048.

17.

Kalteis

Berger

Messie-Werndl

. High ligation combined with stripping and endovenous laser ablation of the great saphenous vein: early results of a randomized controlled study. J Vasc Surg. 2008;47 (4):822–829. doi:10.1016/j.jvs.2007.10.060.

18.

Darwood

Theivacumar

Dellagrammaticas

Mavor

AID

Gough

. Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous varicose veins. Br J Surg. 2008;95 (3):294–301. doi:10.1002/bjs.6101.

19.

Hinchliffe

Ubhi

Beech

Ellison

Braithwaite

. A prospective randomised controlled trial of VNUS closure versus surgery for the treatment of recurrent long saphenous varicose veins. Eur J Vasc Endovasc Surg. 2006;31 (2):212–218. doi:10.1016/j.ejvs.2005.07.005.

20.

Murad

Coto-Yglesias

Zumaeta-Garcia

. A systematic review and meta-analysis of the treatments of varicose veins. J Vasc Surg. 2011;53(5 suppl):49S–65S. doi:10.1016/j.jvs.2011.02.031.

21.

About ACS NSQIP. American College of Surgeons—National Surgical Quality Improvement Project. Web site. http://site.acsnsqip.org/about/. Accessed February 3, 2014.

22.

Bilimoria

Liu

Paruch

. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217 (5):833–842. doi:10.1016/j.jamcollsurg.2013.07.385.

23.

Khuri

Henderson

Daley

. Successful implementation of the department of veterans affairs' National Surgical Quality Improvement Program in the private sector: the patient safety in surgery study. Ann Surg. 2008;248 (2):329–336. doi:10.1097/SLA.0b013e3181823485.

24.

User Guide for the 2011 Participant Use Data File . American College of Surgeons; 2012:1–37. Web site. http://site.acsnsqip.org/participant-use-data-file/. Accessed June 6, 2012.

25.

Mozes

Kalra

Carmo

Swenson

Gloviczki

. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J Vasc Surg. 2005;41 (1):130–135. doi:10.1016/j.jvs.2004.10.045.

26.

Benarroch-Gampel

Sheffield

Boyd

Riall

Killewich

. Analysis of venous thromboembolic events after saphenous ablation. J Vasc Surg Venous Lymphat Disord. 2013;1 (1):26–32. doi:10.1016/j.jvsv.2012.07.006.

27.

van Rij

Chai

Hill

Christie

. Incidence of deep vein thrombosis after varicose vein surgery. Br J Surg. 2004;91 (12):1582–1585. doi:10.1002/bjs.4701.

28.

Schanzer

. Endovenous ablation plus microphlebectomy/sclerotherapy for the treatment of varicose veins: single or two-stage procedure? Vasc Endovascular Surg. 2010;44 (7):545–549. doi:10.1177/1538574410375126.

29.

Giles

Hamdan

Pomposelli

Wyers

Siracuse

Schermerhorn

. Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg. 2010;24 (1):48–56. doi:10.1016/j.avsg.2009.05.003.

30.

Greenblatt

Rajamanickam

Mell

. Predictors of surgical site infection after open lower extremity revascularization. J Vasc Surg. 2011;54 (2):433–439. doi:10.1016/j.jvs.2011.01.034.

31.

Davenport

Xenos

Hosokawa

Radford

Henderson

Endean

. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg. 2009;49 (1):140–147. doi:10.1016/j.jvs.2008.08.052.